Starbucks’ Financial Results Miss Wall Street Targets
Retail coffee chain Starbucks (SBUX) has reported first-quarter financial results that missed Wall Street targets across the board. The Seattle-based company announced earnings per share (EPS) of $0.41 U.S., which was below the $0.49 U.S. consensus expectation of analysts. Revenue in the January through March period totaled $8.76 billion U.S., which fell short of the $8.82 billion U.S. that had been forecast on Wall Street. The poor results sent Starbucks’ stock down 10% in after hours trading. Management acknowledged that its same-store sales continued to decline in this year’s first quarter but said its turnaround strategy is starting to work. Still, the company’s operating margin fell to 6.9% from 12.8% a year earlier as Starbucks spent more money on its revitalization efforts. Labor costs also rose as it hired more baristas.Starbucks’ same-store sales fell for a fifth consecutive quarter. The company’s sales continue to decline as consumers in the U.S. and China, its two biggest markets, seek out cheaper coffee options.The company’s global same-store sales fell 1%, driven by a 2% decline in transactions. In Starbucks’ home market of America, the traffic decline was even steeper.U.S. locations saw transactions fall 4%, dragging its same-store sales down 2%. China’s same-store sales were flat for the quarter, as a lower average ticket offset transaction growth.Last October, Starbucks suspended its forecast for 2025 as it launched its turnaround strategy. The plan has included layoffs for its white-collar workers. In late February, Starbucks announced it would cut 1,100 corporate jobs.Prior to today (April 30), Starbucks’ stock had declined 8% this year to trade at $84.85 U.S. per share.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


